Citation Impact
Citing Papers
Schizophrenia risk from complex variation of complement component 4
2016 StandoutNature
Ehlers-Danlos syndrome type IV
2007
Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type
2010
A review of etomidate for rapid sequence intubation in the emergency department
1997
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2015
Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes
2012
Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR )
2019
ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice
2016
Psoriasis
2021 Standout
Back to basics – how the evolution of the extracellular matrix underpinned vertebrate evolution
2009
Extracellular Matrix Degradation and Remodeling in Development and Disease
2011 Standout
The Lively Legs self-management programme increased physical activity and reduced wound days in leg ulcer patients: Results from a randomized controlled trial
2011
Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2017
Psoriasis
2015 Standout
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
2016 Standout
The Collagen Family
2010 Standout
Airway Management in the Emergency Department: A One-Year Study of 610 Tracheal Intubations
1998 Standout
Ehlers-Danlos syndromes and Marfan syndrome
2008
Hidradenitis suppurativa
2020 Standout
Psoriasis
2016
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
2018
Joint hypermobility syndrome (a.k.a. Ehlers-Danlos Syndrome, Hypermobility Type): an updated critique.
2013
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
2014
Psoriasis Pathogenesis and Treatment
2019 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Abdominal Aortic Aneurysm Is Associated With High Serum Levels of Tenascin-X and Decreased Aneurysmal Tissue Tenascin-X
2006
Psychiatric and psychological aspects in the Ehlers–Danlos syndromes
2017 Standout
Evaluation of Kinesiophobia and Its Correlations with Pain and Fatigue in Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome Hypermobility Type
2013
Development and validation of educational technology for venous ulcer care
2016 Standout
Abdominal Aortic Aneurysm
2006 Standout
Consensus Guidelines for the Management of Plaque Psoriasis
2012
Works of Marisol E. Otero being referenced
Oral retinoic acid metabolism blocking agent RambazoleTMfor plaque psoriasis: an immunohistochemical study
2006
Anti‐adrenal action of a subanaesthetic dose of etomidate
1988
Ulcer-related problems and health care needs in patients with venous leg ulceration: A descriptive, cross-sectional study
2006
‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
2014
Haploinsufficiency of TNXB Is Associated with Hypermobility Type of Ehlers-Danlos Syndrome
2003
Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort
2016
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t
2016